Pfizer 5 XNB (Inlyta 5 mg)

Generic Name: axitinib

Pill imprint Pfizer 5 XNB has been identified as Inlyta 5 mg.

Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Pfizer 5 XNB

Inlyta 5 mg Pfizer 5 XNB
Inlyta
Generic Name:
axitinib
Imprint:
Pfizer
5 XNB
Strength:
5 mg
Color:
Red
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer Inc.
National Drug Code (NDC):
00069-0151
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
magnesium stearate
titanium dioxide
triacetin
ferric oxide red
hypromellose 2910 (15000 mPa.s)

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)